Abstract
The t(12;21)(p13;q22) fusion gene is the most frequent genetic lesion described in precursor B cell acute lymphoblastic leukemia (ALL) of childhood occurring in a quarter of cases. This gene rearrangement is associated with a good outcome presenting a high response rate to chemotherapy. In spite of its potential clinical relevance, the t(12;21) translocation usually goes undetected with conventional cytogenetic procedures. In the present study we utilized an objective flow cytometric approach (multiparametric quantitative analysis) for the phenotypic characterization of this type of ALL. We studied a total of 74 precursor B-ALL children, including 21 t(12;21)+ and 53 t(12;21)− cases. Our results show that the t(12;21)(p13;q22)+ ALLs display a higher intensity of CD10 (P = 0.0016) and HLADR (P = 0.005) expression together with lower levels of the CD20 (P = 0.01), CD45 (P = 0.01), CD135 (P = 0.003) and CD34 (P = 0.03) antigens as compared to the t(12;21)− cases. Moreover, as regards CD34 expression, we observed a more heterogeneous antigen expression within individual patients with higher coefficients of variation (median of 202 vs 88, P = 0.0001). A multivariate analysis disclosed that with the immunophenotypic approach used identification of t(12;21)+ cases can be achieved with a sensitivity of 86% and a specificity of 100%. We conclude that childhood precursor B-ALL carrying the t(12;21) translocation display characteristic phenotypic features which could provide a rapid, simple, sensitive and specific screening method to select for those cases that should undergo confirmatory molecular analysis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
McLean TW, Ringold S, Neuberg D, Stegmaier K, Tantravahi R, Ritz J, Koeffler HP, Takeuchi S, Janssen JWG, Seriu T, Bartram CR, Sallan SE, Gilliland DG, Golub TR . TEL/AML1 dimerizes and is associated with a favourable outcome in childhood acute lymphoblastic leukemia Blood 1996 88: 4252–4258
Romana SP, Poirel H, Leconiat M, Flexor MA, Mauchauffé M, Jonveaux P, Macintyre EA, Berger R, Bernard OA . High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia Blood 1995 86: 4263–4269
Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, Chan GC-F, Pui C-H, Grosveld G, Downing JR . TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis Leukemia 1995 9: 1985–1989
Rubnitz JE, Pui CH, Downing JR . The role of the TEL fusion gene in pediatric leukemias Leukemia 1999 13: 6–13
Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG . Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia Proc Natl Acad Sci USA 1995 92: 4917–4921
Romana SP, Mauchauffé M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA . The t(12;21) of acute lymphoblastic leukemia results in a TEL-AML1 gene fusion Blood 1995 85: 3662–3670
Raynaud S, Cavé H, Baens M, Bastard C, Cacheux V, Grosgeorge J, Guidal-Giroux C, Guo C, Vilmer E, Marynen P, Grandchamp B . The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia Blood 1996 87: 2891–2899
Borkhardt A, Cazzaniga G, Viehmann S, Valsecchi MG, Ludwig WD, Burci L, Mangioni S, Schrappe M, Riehm H, Lampert F, Basso G, Masera G, Harbott J, Biondi A . Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials Blood 1997 90: 571–577
Cayuela JM, Baruchel A, Orange C, Madani A, Auclerc MF, Daniel MT, Schaison G, Sigaux F . TEL/AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia Blood 1996 88: 302–308
Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB . Proposals for the immunological classification of acute leukemias Leukemia 1995 9: 1783–1786
Jennings CD, Foon KA . Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy Blood 1997 90: 2863–2892
De Rossi G, Grossi C, Foa R, Tabilio A, Vegna L, Lo Coco F, Annino L, Camera A, Cascavilla N, Ciolli S, Del Poeta G, Liso V, Mandelli F . Immunophenotype of acute lymphoblastic leukemia cells: the experience of the Italian Cooperative Group (Gimena) Leuk Lymphoma 1993 9: 221–228
Ludwig WD, Reiter A, Loffler H, Gokbuget, Hoelzer D, Riehm H, Thiel E . Immunophenotypic features of childhood and adult acute lymphoblastic leukemia (ALL): experience of the German Multicentre Trials ALL-BFM and GMALL Leuk Lymphoma 1994 13: (Suppl. 1) 71–76
Foon KA, Tood RF III . Immunologic classification of leukemia and lymphoma Blood 1986 68: 1–31
Paietta E . Proposal for the immunological classification of acute leukemias Leukemia 1995 9: 2147–2148
Janossy G, Bollum FJ, Bradstock KF, Ashley J . Cellular phenotypes of normal and leukemic hemopoietic cells determined by analysis with selected antibody combinations Blood 1980 56: 430–441
Ryan DH, Chapple C, Kossover SA, Sandberg AA, Cohen HJ . Phenotypic similarities and differences between cALLA-positive acute lymphoblastic leukemia cells and normal marrow cALLA-positive B cell precursors Blood 1987 70: 814–821
Lamkin T, Brooks J, Annett G, Roberts W, Weinberg K . Immunophenotypic differences between putative hematopoietic stem cells and childhood B-cell precursor acute lymphoblastic leukemia cells Leukemia 1994 8: 1871–1878
Hurwitz CA, Loken MR, Graham ML, Karp JE, Borowitz MJ, Pullen DJ, Civin CI . Asynchronous antigen expression in B lineage acute lymphoblastic leukemia Blood 1988 72: 299–307
Ross CW, Stoolman LM, Schnitzer B, Schlegelmilch JA, Hanson CA . Immunophenotypic aberrancy in adult acute lymphoblastic leukemia Am J Clin Pathol 1990 94: 590–599
Drexler HG, Thiel E, Ludwig WD . Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia Leukemia 1991 5: 637–645
Greaves MF, Chan LC, Furley AJW, Watt SM, Molgaard HV . Lineage promiscuity in hematopoietic differentiation and leukemia Blood 1986 67: 1–11
Ciudad J, San Miguel JF, Lopez Berges MC, Vidriales B, Valverde B, Ocqueteau M, Mateos G, Cabellero MD, Hernendez J, Moro MJ, Mateos MV, Orfao A . Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia J Clin Oncol 1998 16: 3774–3781
Pui CH, Williams DL, Roberson PK, Raimondi SC, Behm FG, Lewis SH, Rivera GK, Kalwinsky DK, Abromowitch M, Crist WM, Murphy SB . Correlation of karyotype and immunophenotype in childhood acute lymphoblastic leukemia J Clin Oncol 1988 6: 56–61
Van Denderen J, Van der Plas D, Meeuwsen T, Zegers N, Boersma W, Grosveld G, Van Ewijk W . Immunologic characterization of the tumor-specific bcr-abl junction in Philadelphia chromosome-positive acute lymphoblastic leukemia Blood 1990 76: 136–141
Tien HF, Wang CH, Lee FY, Liu MC, Chuang SM, Chen YC, Shen MC, Lin DT, Lin KH, Chuu WM . Cytogenetic study of acute lymphoblastic leukemia and its correlation with immunophenotype and genotype Cancer Genet Cytogenet 1992 59: 191–198
Ludwig WD, Bartram CR, Harbott J, Koller U, Haas O, Hansen-Hagge T, Heil G, Seibt-Jung H, Teichmann J, Ritter J, Knapp W, Gadner H, Thiel E, Riehm H . Phenotypic and genotypic heterogeneity in infant acute leukemia. I. Acute lymphoblastic leukemia Leukemia 1989 3: 431–439
Ludwig WD, Bartram CR, Thiel E, Teichmann JV, Harbott J, Reiter A, Riehm H . Childhood acute lymphoblastic leukemia with co-expression of myeloid antigens (My+ALL): incidence, genotype, and clinical significance Blood 1989 74: 197a (Abstr.)
Kita K, Nakase K, Miwa H, Masuya M, Nichii K, Morita N, Takalura N, Otsuij A, Shirakawa S, Ueda T, Nasu K, Kyo T, Dohy H, Kamada N . Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;p22) chromosomal abnormality. Frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34 Blood 1992 80: 470–477
Devaraj PE, Foroni L, Janossy G, Hoffbrand AV, Secker-Walker LM . Expression of the E2A-PBX1 fusion transcripts in t(1;19)(q23;p13) and der(19)t(1;19) at diagnosis and in remission of acute lymphoblastic leukemias with different B lineage immunophenotype Leukemia 1995 9: 821–825
Pui CH, Raimondi SC, Hancock ML, Rivera GK, Ribeiro RC, Mahmoud HH, Sandlund JT, Crist WM, Behm FG . Immunologic, cytogenetic and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19)(q23;p13) or its derivative J Clin Oncol 1994 12: 2601–2606
Borowitz MJ, Hunger SP, Carroll AJ, Shuster JJ, Pullen DJ, Steuber CP, Cleary ML . Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study Blood 1993 82: 1086–1091
Pui CH, Frankel LS, Carroll AJ, Raimondi SC, Shuster JJ, Head DR, Crist WM, Land VJ, Pullen DJ, Steuber P, Behm FG, Borowitz MJ . Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases Blood 1991 77: 440–447
Pui CH . Acute leukemias with the t(4;11)(q21;q23) Leuk Lymphoma 1992 7: 173–179
Baruchel A, Cayuela JM, Ballerini P, Landman-Parker J, Cezard V, Firat H, Haddad E, Auclerc MF, Valensi F, Cayre YE, Macintyre EA, Sigaux F . The majority of myeloid-antigen-positive (My+) childhood B-cell precursor acute lymphoblastic leukaemias express TEL/AML1 fusion transcripts Br J Haematol 1997 99: 101–106
Borowitz MJ, Rubnitz J, Nash M, Pullen DJ, Camitta B . Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group study Leukemia 1998 12: 1764–1770
Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi A, Miniero R, Di Tullio MT, Lo Nigro L, Pession A, Rondelli R, Messina C, Santoro N, Mori PG, De Rossi G, Tamaro P, Silvestri D, Biondi A, Basso G, Masera G . Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study Haematologica 1998 83: 791–799
Golub TR, Barker GF, Lovett M, Gilliland DG . Fusion of the PDGF receptor β to a novel ets-like gene, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation Cell 1994 77: 307–316
Janossy G, Bollum FJ, Bradstock KF, McMichael A, Rapson N, Greaves MF . Terminal transferase-positive human bone marrow cells exhibit the antigenic phenotype of common acute lymphoblastic leukemia J Immunol 1979 123: 1525–1529
Borowitz MJ, Rubnitz J, Nash M, Pullen DJ, Camitta B . Replay: immunophenotypic prediction of TEL/AML1 rearrangement in childhood ALL (letter) Leukemia 1999 13: 983
Orfao A, Chillon MC, Bortoluci AM, Lopez Berges MC, Garcia-Sanz R, Gonzalez M, Tabernero MD, Garcia Marcos MA, Rasillo AI, Hernendez-Rivas J, San Miguel JF . The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalfa gene rearrangements Haematologica 1999 84: 405–412
Faraht N, Lens D, Zomas A, Morilla R, Matutes E, Catovsky D . Quantitative flow cytometry can distinguish between normal and leukemic B-cell precursors Br J Haematol 1995 10: 640–646
Dworzak MN, Fritsch G, Fleischer C, Printz D, Froschl G, Buchinger P, Mann G, Gadner H . Comparative phenotype mapping of normal vs. malignant pediatric B-lymphopoiesis unveils leukemia-associated aberrations Exp Hematol 1998 26: 305–313
Lavabre-Bertrand T, Duperray C, Brunet C, Poncelet P, Exbrayat C, Bourquard P, Lavabre-Bertrand C, Brochier J, Navarro M, Janossy G . Quantification of CD24 and CD45 antigens in parallel allows a precise determination of B-cell maturation stages: relevance for the study of B-cell neoplasias Leukemia 1994 8: 402–408
Weir EG, Cowan K, LeBeau P, Borowitz MJ . A limited panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implication for residual disease detection Leukemia 1999 13: 558–567
Hrusak O, Trka J, Zuna J, Bartunkova J, Stary J . Are we ready to curtail testing for TEL/AML1 fusion (letter)? Leukemia 1999 13: 981–982
Ginaldi L, Matutes E, Farahat N, De Martinis M; Morilla R, Catovsky D . Differential expression of CD3 and CD7 in T-cell malignancies: a quantitative study by flow cytometry Br J Haematol 1996 93: 921–927
Putti MC, Rondelli R, Cocito MG, Aricò M, Sainati L, Conter V, Guglielmi C, Cantù-Rajnoldi A, Consolini R, Pession A, Zanesco L, Masera G, Biondi A, Basso G . Expression of myeloid markers lack prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88–91 studies Blood 1998 92: 795–801
Borowitz MJ, Shuster J, Carroll AJ, Nash M, Look AT, Camitta B, Mahoney D, Lauer SJ, Pullen DJ . Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study Blood 1997 89: 3960–3966
Lavabre-Bertrand T, Janossy G, Ivory K, Peters R, Secker-Walker L, Porwit-MacDonald A . Leukemia-associated changes identified by quantitative flow cytometry: I. CD10 expression Cytometry 1994 18: 209–217
Behm FG, Raimondi SC, Schell MJ, Look AT, Rivera GK, Pui C-H . Lack of CD45 antigen on blast cells in childhood acute lymphoblastic leukemia is associated with chromosomal hyperdiploidy and other favorable prognostic features Blood 1992 79: 1011–1016
Borowitz MJ, Guenter KL, Shults KE, Stelzer GT . Immunophenotyping of acute lymphoblastic leukemia by flow cytometric analysis: use of CD45 as right-angle light scatter to gate on leukemic blasts in three-color analysis Am J Clin Pathol 1993 100: 534–540
Raynaud SD, Dastugue N, Zoccola D, Shurtleff SA, Mathew S and Raimondi SC . Cytogenetic abnormalities associated with the t(12;21): a collaborative study of 169 children with t(12;21)-positive acute lymphoblastic leukemia Leukemia 1999 13: 1325–1330
Acknowledgements
We thank all the investigators from AIEOP Institutions for their collaboration; Maurizio Aricò, MD for helpful discussion and Mr Denis Swift for the editorial scrutiny. This work was supported by AIRC (Associazione Italiana per la Ricerca sul Cancro), MURST ex 40% and 60%; Fondazione Città della Speranza.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
De Zen, L., Orfao, A., Cazzaniga, G. et al. Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: correlation with specific genotype. I. ETV6/AML1 ALLs identification. Leukemia 14, 1225–1231 (2000). https://doi.org/10.1038/sj.leu.2401824
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401824
Keywords
This article is cited by
-
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
Leukemia (2012)
-
Validation of NG2 antigen in identifying BP-ALL patients with MLL rearrangements using qualitative and quantitative flow cytometry: a prospective study
Leukemia (2008)
-
Immunophenotype signature as a tool to define prognostic subgroups in childhood acute myeloid leukemia
Leukemia (2006)
-
Correlation between karyotype and quantitative immunophenotype in acute myelogenous leukemia with t(8;21)
Modern Pathology (2004)
-
Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring
Leukemia (2003)